SCHEMBL9303554

SCHEMBL9303554

N=C(N)c1cccc2cccc(NC(=O)c3ccccc3N=C(N)N)c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.46
▸ RAB9A P51151 3/20 0.46
▸ KDM4E B2RXH2 4/20 0.42
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ MAPT P10636 3/20 0.42
▸ CHRNB2 P17787 1/20 0.41
▸ CHRNB4 P30926 1/20 0.41
▸ CHRNA3 P32297 1/20 0.41
▸ CHRNA4 P43681 1/20 0.41
▸ SIGMAR1 Q99720 3/20 0.41
▸ GRIN2D O15399 1/20 0.41
▸ GRIN3B O60391 1/20 0.41
▸ GRIN1 Q05586 1/20 0.41
▸ GRIN2A Q12879 1/20 0.41
▸ GRIN2B Q13224 1/20 0.41
▸ GRIN2C Q14957 1/20 0.41
▸ GRIN3A Q8TCU5 1/20 0.41
▸ GAA P10253 3/20 0.40
▸ POLB P06746 1/20 0.40
▸ KDR P35968 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9303484 0.85 NPC1 (0.49) NPC1RAB9AKDM4ESMN1; SMN2MAPT
SCHEMBL9303218 0.85 PLAU (0.44) NPC1RAB9AKDM4ESMN1; SMN2MAPT
SCHEMBL9302810 0.83 NPC1 (0.49) NPC1RAB9AKDM4ESMN1; SMN2MAPT
SCHEMBL9303532 0.82 PLAU (0.57) NPC1RAB9ACHRNB2CHRNB4CHRNA3
SCHEMBL9303518 0.81 NPC1 (0.49) NPC1RAB9AKDM4ESMN1; SMN2CHRNB2
SCHEMBL9303327 0.80 RAB9A (0.44) NPC1RAB9AKDM4ESMN1; SMN2MAPT
SCHEMBL9303612 0.80 NPC1 (0.43) NPC1RAB9AKDM4ESMN1; SMN2MAPT
SCHEMBL9302787 0.79 PLAU (0.45) NPC1RAB9APLAUMEN1KMT2A
SCHEMBL9303967 0.79 KCNJ11 (0.43) NPC1RAB9AKDM4ESMN1; SMN2MAPT
SCHEMBL9303538 0.78 DEGS1 (0.46) NPC1RAB9APLAUMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5352704-A Antiviral agents BANYU PHARMACEUTICAL CO., LTD. (JP) 1994-10-04 — — US disclosed
EP-0434432-B1 Guanidinobenzene derivatives BANYU PHARMA CO LTD (JP) 1994-05-04 — — EP disclosed
EP-0434432-A1 Guanidinobenzene derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 1991-06-26 — — EP disclosed
Send feedback